close

Discovery Texas Interventional Psychiatry Launches New Website Detailing FDA-Cleared TMS Therapy for Depression

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The Dallas-Fort Worth practice's new site helps patients explore a non-drug treatment option when medication alone hasn't been enough

-- Discovery Texas Interventional Psychiatry (DTIP) today announced the launch of its new website, discoverytexasinterventionalpsychiatry.com, giving Dallas-Fort Worth area patients a resource for learning about FDA-cleared transcranial magnetic stimulation (TMS) therapy for major depressive disorder and treatment-resistant depression and for requesting a benefits verification online.

The new site explains how TMS works: it uses magnetic pulses to stimulate areas of the brain associated with mood regulation. It has been FDA-cleared for depression since 2008, requires no medication and no sedation, and patients remain awake throughout each session. Most return to their normal daily activities immediately afterward.

The site also explains the two conditions DTIP treats. Major depressive disorder is described, drawing on definitions from the National Institute of Mental Health and MedlinePlus, as a medical condition, not a personal failing, that can affect sleep, energy, concentration, and daily functioning for at least two weeks at a time. Treatment-resistant depression is defined as depression that hasn't responded adequately to two or more antidepressant medications tried at an appropriate dose and duration, a more common experience than many people realize. Both pages point visitors toward the PHQ-9, a standardized questionnaire providers use to track symptom severity over time rather than relying on memory alone.

"Our new website makes it easier for someone to understand TMS before they ever pick up the phone: how the process works, what to expect from a course of treatment, and how their insurance benefits are verified. It's a path forward when medication alone hasn't been enough, and now people can explore it on their own time."

— Michael Banis, Chief Growth Officer, Discovery MSO

The site walks patients through what a course of TMS at DTIP looks like: a consultation to confirm candidacy and verify insurance benefits, a one-time brain mapping session that personalizes the treatment, and a series of short outpatient sessions over several weeks with progress tracked throughout using standard symptom measures. Results vary from person to person, and DTIP's care team coordinates with each patient's existing providers.

The site also answers the questions people tend to have before a first appointment. Sessions use DTIP's MagVenture TMS system, typically run under an hour, and don't require anesthesia; most patients describe a light tapping sensation on the scalp that eases within the first few sessions. Many people continue their current medication throughout a course of TMS unless their provider recommends otherwise, and most return to work or their normal routine immediately afterward. According to research cited on the site from the National Institute of Mental Health and MedlinePlus, TMS carries a low risk of effects on memory or cognitive function relative to some other treatment options. DTIP is careful not to promise a specific outcome, since individual responses vary, but frames TMS as a next step worth discussing when standard treatments haven't been enough.

The website also details DTIP's insurance relationships: the practice is in-network with several major insurance providers, and its team confirms each patient's specific plan benefits, handles prior authorization directly with the insurer, and explains any out-of-pocket cost before a patient commits to anything, so patients are not navigating that process on their own.

Depression and substance use disorders frequently occur together, and the new site connects visitors to fellow Discovery MSO provider Discovery Point Retreat, which treats co-occurring mental health conditions as part of a full continuum of addiction care, so both concerns can be addressed together.

The new website is live now at discoverytexasinterventionalpsychiatry.com, where Dallas-Fort Worth area patients can request a benefits verification online or call (855) 635-4776 to speak with the DTIP team.

About Discovery Texas Interventional Psychiatry

Discovery Texas Interventional Psychiatry (DTIP) is a provider-led psychiatric practice located at 4306 Capitol Ave, Dallas, TX 75204, serving the Dallas-Fort Worth area with FDA-cleared TMS therapy for adults with major depressive disorder and treatment-resistant depression. DTIP is part of Discovery MSO, LLC, alongside fellow provider Discovery Point Retreat. For more information, visit discoverytexasinterventionalpsychiatry.com.

Contact Info:
Name: Michael Banis
Email: Send Email
Organization: Discovery Texas Interventional Psychiatry
Address: 4306 Capitol Ave, Dallas, TX 75204
Phone: (855) 635-4776
Website: https://discoverytexasinterventionalpsychiatry.com

Release ID: 89200635

Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.45
+0.00 (0.00%)
AAPL  310.03
+0.00 (0.00%)
AMD  484.39
+0.00 (0.00%)
BAC  64.23
+0.00 (0.00%)
GOOG  341.28
+0.00 (0.00%)
META  543.67
+0.00 (0.00%)
MSFT  481.63
+0.00 (0.00%)
NVDA  219.74
+0.00 (0.00%)
ORCL  142.79
+0.00 (0.00%)
TSLA  336.87
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.